Listed

Benitec Biopharma Inc.

BNTCNasdaqCIK 1808898HealthcareFiscal year ends Dec 31

Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Benitec Biopharma Inc., Reports and events
FiledFormWhat it isAccession number
2024-09-2616:30 ET10-KAnnual reportPeriod 2024-06-300001193125-24-226968
2024-09-0520:37 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-24-213348
2024-07-2916:28 ETDEF 14AProxy statementPeriod 2024-08-290001193125-24-187599
2024-07-1517:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-179108
2024-07-0116:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-24-173338
2024-05-1619:32 ETS-1Registration statement0001193125-24-139625
2024-05-1308:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-24-136730
2024-05-1308:01 ET10-QQuarterly reportPeriod 2024-03-310001193125-24-136727
2024-04-2916:08 ETSC 13DOwnership report, active investor0000899140-24-000506
2024-04-1921:45 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-101289
2024-04-1808:53 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-100080
2024-03-0816:17 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-063667
2024-02-1308:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-24-032956
2024-02-1308:01 ET10-QQuarterly reportPeriod 2023-12-310001193125-24-032940
2023-12-0716:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-290709
2023-11-3007:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-285671
2023-11-1308:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-275384
2023-11-1308:00 ET10-QQuarterly reportPeriod 2023-09-300001193125-23-275377
2023-10-2006:04 ETDEF 14AProxy statementPeriod 2023-12-060001193125-23-259531
2023-10-1617:29 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-257001
2023-09-2817:19 ET8-K8.01 Other events0001193125-23-245807
2023-09-2108:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-239127
2023-09-2108:00 ET10-KAnnual reportPeriod 2023-06-300001193125-23-239121
2023-09-1817:26 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-237014
2023-08-1116:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-210679
2023-08-1016:42 ET8-K3.01 Delisting notice0001193125-23-209112
2023-08-0708:11 ETS-1/ARegistration statement, amended0001193125-23-204498
2023-08-0308:27 ETS-1/ARegistration statement, amended0001193125-23-202324
2023-07-3108:34 ETS-1/ARegistration statement, amended0001193125-23-198629
2023-07-2514:08 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-193295
2023-07-0716:52 ETS-1Registration statement0001193125-23-183854
2023-06-2608:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-174479
2023-06-1516:20 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-167929
2023-05-1508:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-144217
2023-05-1508:01 ET10-QQuarterly reportPeriod 2023-03-310001193125-23-144211
2023-03-0816:31 ET8-K3.01 Delisting notice0001193125-23-064582
2023-02-1308:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-034348
2023-02-1308:02 ET10-QQuarterly reportPeriod 2022-12-310001193125-23-034339
2023-01-2308:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-012670
2022-12-1319:54 ETS-1Registration statement0001193125-22-303006
2022-12-1207:53 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-22-302288
2022-12-0816:16 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-22-301044
2022-11-1008:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-281980
2022-11-1008:00 ET10-QQuarterly reportPeriod 2022-09-300001193125-22-281978
2022-10-2516:15 ETDEF 14AProxy statementPeriod 2022-12-070001193125-22-268377
2022-10-1816:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-264446
2022-09-1608:58 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-246077
2022-09-1216:20 ETS-1/ARegistration statement, amended0001193125-22-242886
2022-09-0921:27 ETS-1/ARegistration statement, amended0001193125-22-241222
2022-09-0716:16 ET8-K3.01 Delisting notice0001193125-22-240014

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.